George W. Hebard III
2012
In 2012, George W. Hebard III earned a total compensation of $514.5K as Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary at Enzon Pharmaceuticals.
Compensation breakdown
Option Awards | $131,602 |
---|---|
Salary | $226,365 |
Stock Awards | $151,410 |
Other | $5,127 |
Total | $514,504 |
Hebard received $226.4K in salary, accounting for 44% of the total pay in 2012.
Hebard also received $131.6K in option awards, $151.4K in stock awards and $5.1K in other compensation.
Rankings
In 2012, George W. Hebard III's compensation ranked 8,678th out of 11,487 executives tracked by ExecPay. In other words, Hebard earned more than 24.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,678 | 25th |
Manufacturing | 3,157 | 26th |
Chemicals And Allied Products | 847 | 29th |
Drugs | 620 | 33rd |
Biological Products, Except Diagnostic Substances | 103 | 36th |
Hebard's colleagues
We found five more compensation records of executives who worked with George W. Hebard III at Enzon Pharmaceuticals in 2012.
2012
Ana Stancic
Enzon Pharmaceuticals
Chief Financial Officer
2012
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2012
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2012
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2012
Timothy Daly
Enzon Pharmaceuticals